Increased Aβ42(43) from cell lines expressing presenilin 1 mutations

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · see citing works

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · see citing works

The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease

Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · see citing works

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478 · see citing works

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works

Amyloid, the presenilins and Alzheimer’s disease

Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · see citing works

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271 · see citing works

Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo

Thinakaran, G., Borchelt, D., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G. J., Ratovitski, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80291-3 · Cited by 1,009 · see citing works

The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families

Clark, R. F., Hutton, M., Fuldner, M., Froelich, S., Karran, E., Talbot, C., Crook, R., Lendon, C., Prihar, G., He, C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-219 · Cited by 474 · see citing works

A mutation in Alzheimerʼs disease destroying a splice acceptor site in the presenilin-1 gene

Pérez‐Tur, J., Froelich, S., Prihar, G., Crook, R., Baker, M., Duff, K., Wragg, M. A., Busfield, F., Lendon, C. L., Clark, R. F., et al. (1995) · Neuroreport · doi:10.1097/00001756-199512000-00071 · Cited by 264 · see citing works

Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ₄₂₍₄₃₎

Mann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400205 · Cited by 184 · see citing works

The presenilin genes: a new gene family involved in Alzheimer disease pathology

Cruts, M., Hendriks, L., & Van Broeckhoven, C. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1449 · Cited by 163 · see citing works

Complete analysis of the presenilin 1 gene in early onset Alzheimerʼs disease

Hutton, M., Busfield, F., Wragg, M. A., Crook, R., Pérez‐Tur, J., Clark, R. F., Prihar, G., Phillips, H., Wright, K., Baker, M. C., et al. (1996) · Neuroreport · doi:10.1097/00001756-199602290-00029 · Cited by 153 · see citing works

APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease

Broeckhoven, C. V., Backhovens, H., Cruts, M., Martin, J. J., Crook, R., Houlden, H., & Hardy, J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90385-9 · Cited by 126 · see citing works

Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description

Haltia, M., Viitanen, M. H., Sulkava, R. O., Ala‐Hurula, V., Pöyhönen, M., Goldfarb, L. G., Brown, P., Levy, E., Houlde, H., Crook, R., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360307 · Cited by 98 · see citing works

Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor

Fox, N. (1997) · Brain · doi:10.1093/brain/120.3.491 · Cited by 93 · see citing works

Evidence for Allelic Heterogeneity in Familial Early-Onset Alzheimer's Disease

van Duijn, C. M., Broeckhoven, C. V., Hardy, J., Goate, A., Rossor, M. N., Vandenberghe, A., Martin, J. J., Albert Hofman, D., & MULLAN, M. J. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.4.471 · Cited by 25 · see citing works

Presenilin mutations in Alzheimer's disease: molecular models suggest a potential functional locus

Murgolo, N., Brown, J. E., BAYNE, M. L., & Strader, C. D. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)40003-7 · Cited by 9 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · see citing works

Alzheimer's Disease and Parkinson's Disease

Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351 · see citing works

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · see citing works

Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase

Sun, L., Zhou, R., Yang, G., & Shi, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618657114 · Cited by 382 · see citing works

A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

Crook, R., Verkkoniemi, A., Pérez‐Tur, J., Mehta, N. D., Baker, M. C., Houlden, H., Farrer, M. J., Hutton, M., Lincoln, S., Hardy, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-452 · Cited by 347 · see citing works

Amyloid-β Aggregation

Finder, V. H., & Glockshuber, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000100355 · Cited by 350 · see citing works

Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

Hardy, J., Duff, K., Hardy, K. G., Pérez‐Tur, J., & Hutton, M. (1998) · Nature Neuroscience · doi:10.1038/1565 · Cited by 345 · see citing works

Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40

Kumar‐Singh, S., Theuns, J., Broeck, B. V., Pirici, D. N., Vennekens, K., Corsmit, E., Cruts, M., Dermaut, B., Wang, R., & Broeckhoven, C. V. (2006) · Human Mutation · doi:10.1002/humu.20336 · Cited by 320 · see citing works

Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease

Golde, T. E., Eckman, C. B., & Younkin, S. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00043-0 · Cited by 300 · see citing works

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin–1 gene

Larner, A. J., & Doran, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0019-5 · Cited by 256 · see citing works

Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability

De Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223 · see citing works

Molecular genetics of Alzheimer's disease: An update

Brouwers, N., Sleegers, K., & Broeckhoven, C. V. (2008) · Annals of Medicine · doi:10.1080/07853890802186905 · Cited by 208 · see citing works

Alzheimer's Disease and the Amyloid β Protein

Small, D. H., & McLean, C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730443.x · Cited by 142 · see citing works

Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms

Forloni, G., Terreni, L., Bertani, I., Fogliarino, S., Invernizzi, R. W., Assini, A., Ribizzi, G., Negro, A., Calabrese, E., & Volonté, M. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00076-3 · Cited by 132 · see citing works

Genetic architecture of Alzheimer's disease

Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126 · see citing works

Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic mice

Alley, G. M., Bailey, J. A., Chen, D., Ray, B., Puli, L., Tanila, H., Banerjee, P., & Lahiri, D. K. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22172 · Cited by 124 · see citing works

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

Koivunen, J., Verkkoniemi, A., Aalto, S., Paetau, A. E., Ahonen, J.-P., Viitanen, M. H., Någren, K., Rokka, J., Haaparanta‐Solin, M., Kalimo, H., et al. (2008) · Brain · doi:10.1093/brain/awn107 · Cited by 117 · see citing works

Aβ profiles generated by Alzheimer’s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset

Petit, D., Fernández, S. G., Zoltowska, K. M., Enzlein, T., Ryan, N. S., O’Connor, A., Szaruga, M., Hill, E., Vandenberghe, R. R., Fox, N. C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01518-6 · Cited by 110 · see citing works

Quantitative neuropathological changes in presymptomatic Huntington's disease

Gómez‐Tortosa, E., MacDonald, M. E., Friend, J. C., Taylor, S. A., Weiler, L., Cupples, L. A., Srinidhi, J., Gusella, J. F., Bird, E. D., Vonsattel, J., et al. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1 · Cited by 170 · see citing works

Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein

Citron, M., Eckman, C. B., Diehl, T. S., Corcoran, C., Ostaszewski, B. L., Xia, W., Levesque, G., St. George Hyslop, P., Younkin, S. G., & Selkoe, D. J. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0183 · Cited by 101 · see citing works

Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42

Duering, M., Grimm, M. O. W., Grimm, H. S., Schröder, J., & Hartmann, T. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.002 · Cited by 98 · see citing works

Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.

Kumar, N., Kumar, V., Anand, P., Kumar, V. V., Dwivedi, A. R., & Kumar, V. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116742 · Cited by 81 · see citing works

Seladin-1 transcription is linked to neuronal degeneration in Alzheimer’s disease

Iivonen, S., Hiltunen, M., Alafuzoff, I. I., Mannermaa, A., Kerokoski, P., Puoliväli, J. T., Salminen, A., Helisalmi, S., & Soininen, H. S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00180-x · Cited by 96 · see citing works

Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer's Disease by Increased A 42 Secretion

Jonghe, C. D., MarcCruts, Rogaeva, E. A., Tysoe, C. J., Singleton, A., Vanderstichele, H., Meschino, W. S., Dermaut, B., Vanderhoeven, I., Backhovens, H., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1529 · Cited by 93 · see citing works

Clinical, Pathological, and Biochemical Spectrum of Alzheimer Disease Associated With PS-1 Mutations

Lleó, A., Berezovska, O., Growdon, J. H., & Hyman, B. T. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200403000-00006 · Cited by 92 · see citing works

A Presenilin 1 Mutation Associated with Familial Frontotemporal Dementia Inhibits γ-Secretase Cleavage of APP and Notch

Amtul, Z., Lewis, P. A., Piper, S. C., Crook, R., Baker, M. C., Findlay, K. A., Singleton, A., Hogg, M. C., Younkin, L. H., Younkin, S. G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0473 · Cited by 89 · see citing works

Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes

Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 79 · see citing works

FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Aβ

Shioi, J., Georgakopoulos, A., Mehta, P. D., Kouchi, Z., Litterst, C. M., Baki, L., & Robakis, N. K. R. K. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04391.x · Cited by 78 · see citing works

Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified γ-Secretase Complexes

Cacquevel, M., Aeschbach, L., Houacine, J., & Fraering, P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035133 · Cited by 75 · see citing works

Evidence That Intramolecular Associations between Presenilin Domains Are Obligatory for Endoproteolytic Processing

Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T., & Thinakaran, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13818 · Cited by 74 · see citing works

Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models

Reddy, P. H., & McWeeney, S. K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.014 · Cited by 73 · see citing works

Alzheimer's disease with spastic paresis and cotton wool type plaques

Tabira, T., Chui, D. H., Nakayama, H., Kuroda, S., & Shibuya, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10392 · Cited by 65 · see citing works

Presenilin-1 is located in rat mitochondria

Ankarcrona, M., & Hultenby, K. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00735-0 · Cited by 63 · see citing works

Substrate‐Bound β‐Amyloid Peptides Inhibit Cell Adhesion and Neurite Outgrowth in Primary Neuronal Cultures

Postuma, R. B., He, W., Nunan, J., Beyreuther, K. T., Masters, C. L., Barrow, C. J., & Small, D. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741122.x · Cited by 56 · see citing works

Clinical-Genetic Correlations in Familial Alzheimer's Disease Caused by Presenilin 1 Mutations

Gómez‐Tortosa, E., Barquero, S., Barón, M., Gil-Neciga, E., Castellanos, F., Zurdo, M., Manzano, S., Muñoz, D. G., Jiménez‐Huete, A., Rábano, A., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1292 · Cited by 53 · see citing works

The Presenilin 1 ΔE9 Mutation Gives Enhanced Basal Phospholipase C Activity and a Resultant Increase in Intracellular Calcium Concentrations

Cedazo-Mı́nguez, Á., Popescu, B. O., Ankarcrona, M., Nishimura, T., & Cowburn, R. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112117200 · Cited by 52 · see citing works

Modeling Clinically Heterogeneous Presenilin Mutations with Transgenic Drosophila

Seidner, G. A., Ye, Y., Faraday, M. M., Alvord, W. G., & Fortini, M. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.004 · Cited by 45 · see citing works

Evidence That Aβ42 Plasma Levels in Presenilin-1 Mutation Carriers Do not Allow for Prediction of Their Clinical Phenotype

Jonghe, C. D., Cras, P. P., Vanderstichele, H., Cruts, M., Vanderhoeven, I., Smouts, I., Vanmechelen, E., Martin, J.-J., Hendriks, L., & Broeckhoven, C. V. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0247 · Cited by 45 · see citing works

Antisense‐Induced Reduction of Presenilin 1 Expression Selectively Increases the Production of Amyloid β42 in Transfected Cells

Refolo, L. M., Eckman, C., Prada, C.-M., Yager, D., Sambamurti, K., Mehta, N. D., Hardy, J., & Younkin, S. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732383.x · Cited by 44 · see citing works

Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease

Izco, M., Martinez, P. M., Corrales, A., Fandos, N., García-Cerro, S., Insua, D., Montañés, M., Pérez‐Grijalba, V., Rueda, N., Vidal, V., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.003 · Cited by 43 · see citing works

Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitiZe SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis

Tanii, H., Ankarcrona, M., Flood, F., Nilsberth, C., Mehta, N. D., Pérez‐Tur, J., Winblad, B. G., Benedikz, E., & Cowburn, R. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00432-7 · Cited by 42 · see citing works

Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin‐1 gene show an unusual but characteristic β‐amyloid pathology known as ‘cotton wool’ plaques

Mann, D. M. A., Takeuchi, A., Sato, S., Cairns, N. J., Lantos, P. L., Rossor, M. N., Haltia, M., Kalimo, H., & Iwatsubo, T. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00316.x · Cited by 41 · see citing works

Mutant Presenilin 1 Increases the Levels of Alzheimer Amyloid β‐Peptide Aβ42 in Late Compartments of the Constitutive Secretory Pathway

Petanceska, S. S., Seeger, M., Checler, F., & Gandy, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741878.x · Cited by 40 · see citing works

Alzheimer’s Disease: Genes, Pathogenesis and Risk Prediction

Sleegers, K., & van Duijn, C. M. (2001) · Public Health Genomics · doi:10.1159/000064193 · Cited by 39 · see citing works

Molecular Pathology of Alzheimer’s Disease and Related Disorders

Ginsberg, S. D., Schmidt, M. L., Crino, P. B., Eberwine, J. H., Lee, V. M. ‐., & Trojanowski, J. Q. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_17 · Cited by 38 · see citing works

X11α impairs γ‐ but not β‐cleavage of amyloid precursor protein

King, G. D., Cherian, K., & Turner, R. S. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02234.x · Cited by 36 · see citing works

The Functions of the Amyloid Precursor Protein Gene

Panegyres, P. K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 36 · see citing works

Aberrant Presenilin-1 Expression Downregulates LDL Receptor-Related Protein (LRP): Is LRP Central to Alzheimer's Disease Pathogenesis?

Uden, E. V., Carlson, G. A., George‐Hyslop, P. S., Westaway, D. A., Orlando, R. A., Mallory, M. E., Rockenstein, E. M., & Masliah, E. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0772 · Cited by 35 · see citing works

Secretases as therapeutic targets for the treatment of Alzheimer's disease

Dominguez, D. I., Strooper, B. D., & Annaert, W. G. (2001) · Amyloid · doi:10.3109/13506120109007356 · Cited by 33 · see citing works

Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease

Hriday, K. D. (2007) · Frontiers in bioscience · doi:10.2741/2723 · Cited by 33 · see citing works

The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment

Ma, F., Akolkar, H., Xu, J., Liu, Y., Popova, D., Xie, J., Youssef, M. M., Benosman, R. B., Hart, R. P., & Herrup, K. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0172-22.2023 · Cited by 31 · see citing works

Stem cell strategies for neuroreplacement therapy in Alzheimer's disease

Sugaya, K., & Brannen, C. L. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1424 · Cited by 31 · see citing works

Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy

Yasuda, M. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.2.220 · Cited by 30 · see citing works

Protein Kinase C Activation Potentiates the Rapid Secretion of the Amyloid Precursor Protein from Rat Cortical Synaptosomes

McLaughlin, M., & Breen, K. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720273.x · Cited by 28 · see citing works

Mutational Analysis of Intrinsic Regions of Presenilin 2 That Determine Its Endoproteolytic Cleavage and Pathological Function

Shirotani, K., Takahashi, K., Araki, W., Maruyama, K., & Tabira, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3681 · Cited by 27 · see citing works

Twenty-nine missense mutations linked with familial Alzheimer's disease alter the processing of presenilin 1

Murayama, O., Murayama, M., Honda, T., Sun, X., Nihonmatsu, N., & Takashima, A. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00034-2 · Cited by 25 · see citing works

Caspase cleavage of exon 9 deleted presenilin‐1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH‐SY5Y neuroblastoma cells

Popescu, B. O., Cedazo-Mı́nguez, Á., Popescu, L. M., Winblad, B. G., Cowburn, R. F., & Ankarcrona, M. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1204 · Cited by 21 · see citing works

Transgenic Models of Alzheimer's Disease

Sugarman, M. C., Hinton, S. F., & LaFerla, F. M. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_2 · Cited by 20 · see citing works

A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: Clinical, neuroimaging, and neuropathological findings

Kim, J., Bagyinszky, E., Chang, Y. H., Choe, G., Choi, B., An, S. S. A., & Kim, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.040 · Cited by 20 · see citing works

Alzheimer's disease: Genetic evidence points to a single pathogenesis

Hardy, J. (2003) · Annals of Neurology · doi:10.1002/ana.10624 · Cited by 19 · see citing works

Markers of apoptosis and models of programmed cell death in Alzheimer’s disease

Hugon, J., Terro, F., Esclaire, F., & Yardin, C. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_15 · Cited by 19 · see citing works

Alzheimer’s disease basics: we all should know

Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19 · see citing works

The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer’s disease model

He, Q., Huang, G. J., Chen, Y., Wang, X., Huang, Z., & Chen, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2339-0 · Cited by 17 · see citing works

Novel PSEN1 p.Gly417Ala mutation in a Korean patient with early-onset Alzheimer's disease with parkinsonism

Giau, V. V., Wang, M. J., Bagyinszky, E., Youn, Y. C., An, S. S. A., & Kim, S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.003 · Cited by 16 · see citing works

Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review

Zhang, S., Lei, C., Liu, P., Zhang, M., Tao, W., Liu, H., & Liu, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.003 · Cited by 16 · see citing works

Expression of presenilin-1 and Notch-1 receptor in human embryonic CNS

Kostyszyn, B., Cowburn, R. F., Seiger, Å., Kjældgaard, A., & Sundström, E. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00045-8 · Cited by 16 · see citing works

Targeting APP metabolism for the treatment of Alzheimer's disease

Sambamurti, K., Hardy, J., Refolo, L. M., & Lahiri, D. K. (2002) · Drug Development Research · doi:10.1002/ddr.10077 · Cited by 14 · see citing works

Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease

Chan, H. H., Koh, R. Y., Lim, C. L., & Leong, C. O. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191023102422 · Cited by 14 · see citing works

Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer’s disease

Combarros, O., Alvarez-Arcaya, A., Oterino, A., Berciano, J., Delgado‐Rodríguez, M., Peña, N., Fernández‐Viadero, C., Pérez-López, J. L., Setién, S., & Carvajal, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00254-3 · Cited by 14 · see citing works

Distribution of presenilin 1 and 2 and their relation to Notch receptors and ligands in human embryonic/foetal central nervous system

Kostyszyn, B., Cowburn, R. F., Seiger, Å., Kjældgaard, A., & Sundström, E. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.04.005 · Cited by 13 · see citing works

Presenilin expression during induced differentiation of the human neuroblastoma SH-SY5Y cell line

Flood, F., Sundström, E., Samuelsson, E., Wiehager, B., Seiger, Å., Johnston, J. A., & Cowburn, R. F. (2003) · Neurochemistry International · doi:10.1016/j.neuint.2003.09.002 · Cited by 13 · see citing works

Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life

Kauwe, J. S. K., Wang, J., Chakraverty, S., Goate, A., & Henao‐Martínez, A. F. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.029 · Cited by 13 · see citing works

Akt activity in presenilin 1 wild‐type and mutation transfected human SH‐SY5Y neuroblastoma cells after serum deprivation and high glucose stress

Vestling, M., Wiehager, B., Tanii, H., & Cowburn, R. F. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10006 · Cited by 13 · see citing works

Transcriptional regulation of the presenilin-1 gene controls gamma-secretase activity

Das, H. K. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e61 · Cited by 12 · see citing works

La Lunga Attesa : Towards a Molecular Approach to Neuroimaging and Therapeutics in Alzheimer's Disease

Villemagne, V. L., Ng, S., Cappai, R., Barnham, K. J., Fodero‐Tavoletti, M. T., Rowe, C. C., & Masters, C. L. (2006) · The Neuroradiology Journal · doi:10.1177/197140090601900406 · Cited by 12 · see citing works

Aβ43 levels determine the onset of pathological amyloid deposition

Tambini, M. D., Yin, T., Yesiltepe, M., Breuillaud, L., Zehntner, S. P., d'Abramo, C., Giliberto, L., & D'Adamio, L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104868 · Cited by 8 · see citing works

A Pathogenic Variant p.Phe177Val in PSEN1 Causes Early-Onset Alzheimer’s Disease in a Chinese Family

Jiang, B., Bi, M., Li, J., Liu, Q., Xiao, N., Fang, J., Shi, M.-Y., Yu, Z.-W., Ma, Q., Tong, S., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00713 · Cited by 8 · see citing works

Twenty Years of Presenilins—Important Proteins in Health and Disease

Walter, J. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00163 · Cited by 7 · see citing works

Adverse effects and interactions with other drugs

Schmidt, D. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8759-5_10 · Cited by 6 · see citing works

Potential therapeutic targets for Alzheimer’s disease

McKeon‐O'Malley, C., Saunders, A. J., Bush, A. I., & Tanzi, R. E. (1998) · Emerging Therapeutic Targets · doi:10.1517/14728222.2.2.157 · Cited by 6 · see citing works

A Novel Approach for Studying Endogenous Aβ Processing Using Cultured Primary Neurons Isolated from APP Transgenic Mice

Qiu, Z., Naten, D. L., Liston, J. C., Yess, J., & Rebeck, G. W. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7703 · Cited by 5 · see citing works

The Aβcentric Pathway of Alzheimer’s Disease

Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R. A., Opazo, C., Novakovic, K. E., Rowe, C. C., & Masters, C. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_2 · Cited by 4 · see citing works

Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila

Wangler, M. F., Reiter, L. T., Zimm, G. G., Trimble-Morgan, J., Wu, J. Y., & Bier, E. (2011) · Protein & Cell · doi:10.1007/s13238-011-1073-7 · Cited by 3 · see citing works

Aβ 42 oligomers impair the bioenergetic activity in hippocampal synaptosomes derived from APP-KO mice

Beckert, B., Acker‐Palmer, A., & Volknandt, W. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0238 · Cited by 3 · see citing works

Stress steroids as accelerators of Alzheimer's disease. : Effects of chronically elevated levels of allopregnanolone in transgenic AD models.

Bengtsson, S. K. S. (2013) · DiVA at Umeå University (Umeå University) · Cited by 3 · see citing works

The amyloid precursor protein modulates the position and length of the axon initial segment offering a new perspective on Alzheimer’s disease geneticsPreprint

Ma, F., Xu, J., Liu, Y., Popova, D., Youssef, M. M., Hart, R. P., & Herrup, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.23.477413 · Cited by 2 · see citing works

Down Syndrome, Antioxidant Balance and the “Gene Dosage Effect” Hypothesis

de Haan, J. B., Crack, P. J., Pritchard, M. A., & Kola, I. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50150-2 · Cited by 1 · see citing works

Towards individualized medicine: flies lead the way

Elliott, J. L., & Yin, J. C. P. (2007) · Future Neurology · doi:10.2217/14796708.2.4.389 · Cited by 1 · see citing works

Chapter 1 Amyloid and Amyloid-Like Protein Aggregates in Neurodegenerative Disease

Golde, T. E. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70052-8

Characterization of a novel interaction between presenilin-1 and monoamine oxidase-A

Gabriel, G. G. (2008) · University Library - University of Saskatchewan (University of Saskatchewan)

CHAPTER 5.6 Identification and functional analysis of genes and genetic risk factors in Alzheimer's disease

Jonghe, C. D., & Broeckhoven, C. V. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80063-7

The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: II Experimental Evidence and Clinical Studies

Panegyres, P. K., & Atkins, E. (2011) · Neuroscience &amp Medicine · doi:10.4236/nm.2011.23033

X11a impairs c- but not b-cleavage of amyloid precursor protein

King, G. D., Cherian, K., & Turner, R. S. (2004)

Genetic and Expressional Studies of Alzheimer's Disease

Iivonen, S. (2005)

Molecular Mechanisms of Neuroprotection and Cognitive Enhancement by an Alternative drug Centella asiatica

Ahuja, M. (2013)

The Correlation between Genotype and Phenotype of Alzheimer's Disease

Li, H. L., Jiang, B., & Wu, Z. Y. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000417

A Young Man with Memory and Walking Difficulties

Shin, M., Chamoun, M., Pascoal, T. A., Savard, M., Soucy, J., Guiot, M. C., Rosa‐Neto, P., & Gauthier, S. G. (2021) · Cambridge University Press eBooks · doi:10.1017/9781316941294.004

Tau Transgenic Mouse Models in Therapeutic Development

Roder, H. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_4

Aß Toxicity in Alzheimer’s Disease

Klein, W. L. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_1 · Cited by 14 · see citing works

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works

Presenilin 1 Mutations Converge on Aβ42/Aβ40 Elevation via Distinct Mechanisms

Bestard‐Lorigados, I., Sterling, K., Li, L., Lin, Z., Wu, Z., Zhu, Q., Pan, W., Cai, F., & Song, W. (2026) · MedComm · doi:10.1002/mco2.70978

Enhancement of amyloid β 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease

Murayama, O., Tomita, T., Nihonmatsu, N., Murayama, M., Sun, X., Honda, T., Iwatsubo, T., & Takashima, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00187-1 · Cited by 126 · see citing works

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271 · see citing works

Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein

Citron, M., Eckman, C. B., Diehl, T. S., Corcoran, C., Ostaszewski, B. L., Xia, W., Levesque, G., St. George Hyslop, P., Younkin, S. G., & Selkoe, D. J. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0183 · Cited by 101 · see citing works